Neurosciences

Nervous system diseases

Klotho Neurosciences Expands into New Technologies for Improved Muscle Strength, Bone Health, and Longevity Indicators

Klotho Neurosciences, Inc., a biogenetics company, is evaluating the acquisition of complementary technologies aimed at supporting healthy brain function, organ health, and longevity. The company is building upon its core programs targeting brain aging and neurodegenerative diseases, such as ALS, Alzheimer's, and Parkinson's, by expanding into

Artificial neural networks

Breakthrough in Biomedical Imaging Analysis: Deep Neural Networks Achieve High Accuracy in Cell Identification and Alignment

Researchers have developed a series of deep neural networks that enable automatic non-rigid registration and cell identification in complex cellular tissues. The networks, trained in the context of freely moving and deforming invertebrate nervous systems, demonstrate high accuracy in aligning neurons over time and annotating cell types. The technology has

Artificial neural networks

Breakthrough in Neuromorphic Computing: Tsinghua University Researchers Develop Bio-Realistic and Versatile Artificial Dendrites

Neuromorphic computing, a rapidly emerging field that draws inspiration from the brain, has made significant strides in recent years. Researchers at Tsinghua University, led by Yifei Yang, have made a groundbreaking discovery that challenges traditional understanding of neural networks. According to a recent study published in the journal Neuromorphic Computing

Artificial neural networks

Neural Networks Uncover Human Decision-Making Patterns through Symbolic Regression

Researchers have made a breakthrough in understanding human decision-making by combining artificial neural networks (ANNs) with symbolic regression. This approach allows for the extraction of an expressive and interpretable model that specifies how individuals evaluate decision-relevant information during choice. The model was able to account for behavior in the researchers&

Gene expression

AbbVie and ADARx Collaborate on Next-Generation siRNA Therapies for Neuroscience, Immunology, and Oncology

AbbVie and ADARx Pharmaceuticals have announced a collaboration and license option agreement to develop small interfering RNA (siRNA) therapeutics across multiple disease areas, including neuroscience, immunology, and oncology. This partnership will leverage ADARx's RNA discovery expertise and proprietary siRNA technology, combined with AbbVie's expertise in antibody